• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MAQUET CARDIOPULMONARY AG QUART ARTERIAL FILTER, MODEL HBF 140; FILTER, BLOOD, CARDIOPULMONARY BYPASS, ARTERIAL LINE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MAQUET CARDIOPULMONARY AG QUART ARTERIAL FILTER, MODEL HBF 140; FILTER, BLOOD, CARDIOPULMONARY BYPASS, ARTERIAL LINE Back to Search Results
Model Number HBF 140-J
Device Problem Leak/Splash (1354)
Patient Problem No Patient Involvement (2645)
Event Date 11/15/2018
Event Type  malfunction  
Manufacturer Narrative
(b)(4).A follow-up medwatch will be submitted when additional information becomes available.(b)(4).
 
Event Description
As stated by the customer: during incoming goods inspection leakage at the arterial filter has been detected.No patient involvement.(b)(4).
 
Manufacturer Narrative
Investigation: the arterial filter quart has been returned for further investigation at maquet laboratory.Maquet medical systems,usa(importer)submits this report on behalf of the legal manufacturer of the device maquet cardiopulmonary (b)(4).Rastatt, germany.A follow-up medwatch will be submitted when additional information becomes available.Reference exemption # (b)(4).Importer- maquet medical systems usa (b)(4).Contact person- (b)(6).According to the investigation report, dated on 2019-01-25, the leakage of the quart could be confirmed.During leak test at the laboratory it has been found a leakage between the cover and the housing, near the bypass-tap (white) of the quart.Thus the failure could be confirmed.Most probable root cause could be determined as bad welding between the cover and the housing.The data is also being handled through a designated maquet cardiopulmonary trending and applicable investigation process.Due to this no further investigation initiations will be completed at this time.Correction: according to complaint report, dated on (b)(6)2018, the issue has been detected prior to use.No patient involvement.The set (incl.Quart) was replaced before patient treatment.Corrective action: since the reported failure did not contribute to a death or serious injury no corrective action is needed.In addition at this time it cannot be concluded that this is a systemic error.No corrective action is needed.
 
Event Description
Ref.:(b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
QUART ARTERIAL FILTER, MODEL HBF 140
Type of Device
FILTER, BLOOD, CARDIOPULMONARY BYPASS, ARTERIAL LINE
Manufacturer (Section D)
MAQUET CARDIOPULMONARY AG
rastatt
GM 
MDR Report Key8138253
MDR Text Key129597824
Report Number8010762-2018-00319
Device Sequence Number1
Product Code DTM
Combination Product (y/n)N
PMA/PMN Number
K001787
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional
Type of Report Initial,Followup
Report Date 01/30/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/06/2018
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date01/31/2020
Device Model NumberHBF 140-J
Device Catalogue Number701031617
Device Lot Number70122711
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer01/03/2019
Date Manufacturer Received11/22/2018
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-